It has recently been shown that the iron isotopic composition of blood differs between individuals and genders which is supposed to reflect individual differences in iron metabolism. We hypothesized that patients suffering from hereditary hemochromatosis would demonstrate alterations in the iron isotopic composition of blood due to persistent upregulation of intestinal iron absorption. Blood of 30 patients with homozygous C282Y hemochromatosis was analyzed for iron isotopic composition by a newly developed technique using multicollector inductively coupled plasma mass spectrometry (MC-ICP-MS). Blood of hemochromatosis patients is characterized by a higher 56 Fe/ 54 Fe isotope ratio than blood of normal individuals, which are either members of an age-matched control group (n=10, p=0.0003) or young adults (n=36, p<0.0001). In patients with hereditary hemochromatosis, the 56 Fe/ 54 Fe isotope ratio of blood significantly correlates with total body iron accumulation, severity of clinical disease, and the need for regular phlebotomies to prevent iron reaccumulation. We conclude that blood of patients with hereditary hemochromatosis contains more of the heavier iron isotopes than blood of normal individuals. Primary determinant of the iron isotopic composition of blood appears to be isotope-sensitive iron absorption in the intestine and the efficiency of this process.
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Introduction
Hemochromatosis is a frequent genetic disorder in populations of European ancestry that is characterised by progressive iron overload of tissues due to an ineffective control of intestinal iron absorption. Following identification of the HFE gene, 1 several studies showed that about 90% of the patients with clinical features of hemochromatosis are homozygous for a C282Y mutation of the HFE gene. 2 Estimates of gene frequency range from 5-10% with a homozygote frequency of 0.2-0.5% in Caucasian populations. [3] [4] [5] Typical clinical manifestations are hepatic fibrosis, arthropathies, diabetes mellitus, cardiopathy, and hypogonadism. Epidemiological studies indicate, however, a low clinical penetrance of the homozygous HFE C282Y mutation. 3, [6] [7] Iron homeostasis is maintained by the body by regulating iron absorption in the proximal small intestine. [8] [9] Heme-bound iron such as myoglobin (and hemoglobin) in foods of animal origin is taken up by an endocytotic process in which the porphyrin ring of the heme molecule is broken up within the epithelial cell. [10] [11] Uptake of non-heme iron, mostly from plant foods, is mediated by ferric reductase and divalent metal transporter-1 (DMT-1) [12] [13] [14] or, possibly, by the integrin-mobilferrin-paraferritin pathway. [15] [16] An iron-regulated transporter 1 (IREG1) is involved in subsequent iron transfer from the epithelial cell to blood circulation . 17 There is no satisfactory technique available to date to measure regulation of intestinal iron absorption.
Measurements by conventional tracer techniques using stable or radioactive isotopes are jeopardized by physiological day-to-day variations of iron absorption. Substantial isotope effects are known in nature for a number of light elements such as hydrogen, oxygen and carbon. Until recently, isotope effects were considered to be too small to be measurable for most of the heavier elements such as iron. Using multicollector inductively coupled plasma mass spectrometry (MC-ICP-MS), Walczyk and Blanckenburg demonstrated that human tissues are depleted in heavy iron isotopes compared to the diet and the geosphere. 19 Each individual bears a distinct 56 Fe/ 54 Fe isotope ratio in the blood which is, on average, lower in males than in females. [19] [20] It has been hypothesized that the iron isotopic composition is altered during intestinal absorption. Stability of the iron isotopic signature in blood over one year was recently shown in a healthy subject. 20 In the present study, we show that hemochromatosis patients have an altered iron isotopic composition of blood when compared to normal controls. This strengthens the hypothesis that the iron isotopic composition of blood is primarily determined by the efficiency at which iron is absorbed from the diet.
Study Design
Iron isotopic composition of blood was compared between 30 patients with homozygous C282Y hemochromatosis and 2 control groups, i.e., an age-matched control group of 10 elderly subjects, and 36 young adults included in a previous study.
19

Study Patients
The study protocol was approved by the ethical committee of the University Hospital of Zurich, Switzerland. All patients gave written informed consent to participate in the study. 30 patients with established diagnosis of hemochromatosis were enrolled showing a homozygous C282Y mutation of the HFE gene and serum ferritin concentration above the reference range at time of diagnosis. Clinical manifestations, histological findings, laboratory results, and amounts of iron removed by phlebotomy were assessed by patients' history and from their medical records. As an age-matched control group, 10 patients without history of blood donation or disorders of iron metabolism were recruited. They were not tested for HFE genotype as they all had transferrin saturations below 45%. Four of 5 females included in this control group did not have menstrual blood loss for 10 years.
Assessment of biochemical variables and clinical manifestations
When included in this study, 22 of 30 hemochromatosis patients had completed iron depletion therapy and continued regular maintenance therapy (referred to as treated patients). In 8 patients, either no phlebotomy therapy ever (2 patients), no phlebotomies during the last 2 years (5 patients), or inappropriate phlebotomy therapy (1 patient) had been carried out (referred to as untreated patients). Iron removal by phlebotomy (500 ml blood 250 mg iron)
was assessed as (a) total amount of iron removed to achieve serum ferritin within the reference range (iron depletion therapy) and (b) iron removed per year to maintain ferritin Assessing total number of clinical manifestations, histological examination of liver tissue was used as primary determinant, elevated ALT was considered in patients without biopsy. All patients with liver disease were serologically tested for chronic hepatitis B and C virus infection. Habitual alcohol intake was estimated by interviewing the patients. Diabetes mellitus, cardiopathy, and hypogonadismus were taken over as established diagnosis from medical records; arthropathy of metacarpophalangeal joints was taken over as established diagnosis or assessed by clinical investigation.
Iron isotope analysis
High-precision iron isotope ratios were measured at the University of Hanover, Germany, by multicollector ICP-MS (Neptune, ThermoFinnigan, Bremen, Germany). 21 Venous blood samples (0.5 ml) were mineralized by microwave digestion and iron was purified by anion 
Genetic analysis
HFE gene C282Y (G845A) mutation was determined by LightCycler PCR and melting curve analyses using ToolSets with specific primers and fluorescent probes according to the manufacturers' instructions (Roche Molecular Biochemicals, Rotkreuz, Switzerland; Genes-4U AG, Zurich, Switzerland).
Statistical Analysis
Evaluations were performed using Statistica version 6. All comparisons of this study were done using either Student's t-test, Chi-square test, or Spearman rank order correlation.
Threshold of significance was defined as =0.05.
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Results
Iron isotopic composition of blood in hemochromatosis patients
The iron isotopic composition of blood obtained from hemochromatosis patients (n=30) was compared to that of two control groups. The first control group consisted of elderly subjects (n=10, range 44-72 years) without history of disorders of iron metabolism or blood donation who were not significantly different from the patient group regarding age (p=0.95) and gender (p=0.86). The second control group consisted of young adults (n=36, range 20-32 years) included in a previous study. 19 Blood of patients with hereditary hemochromatosis contains more of the heavier iron isotopes than blood of normal individuals, i.e. it is characterized by a higher 56 Fe/ 54 Fe isotope ratio. in the age-matched control group (p=0.0003) and -2.58±0.25‰ in normal young adults (p<0.0001).
Influence of gender, age and phlebotomy therapy
The difference in the iron isotopic composition of blood ( 56 Fe/ 54 Fe) between treated hemochromatosis patients and the two control groups was found to be more accentuated in males than in females, see Table 1 . An effect of gender on the iron isotopic composition of blood was observed in a previous study, i.e., blood of young males was found to be characterized by a significantly lower 56 Fe/ 54 Fe isotopic ratio than blood of young females. Table 2 . Less common manifestions of hemochromatosis such as diabetes mellitus, cardiopathy, or hypogonadism were also observed among the study patients, but prevalences were too low for proper statistical evaluation. Fe isotope ratio of absorbed iron increases and approaches the value of dietary iron. Figure 2 illustrates how isotope fractionation of dietary iron may occur during the absorption process. Iron is absorbed from two major dietary pools, i.e., foods of animal origin containing primarily heme-bound iron [10] [11] and plant foods containing non-heme iron. [13] [14] Isotope effects (isotope fractionation) may be induced by preferential uptake of lighter isotopes of non-heme iron by DMT-1 and/or iron release from the epithelial cell into the circulatory system by IREG1 and/or preferential deposition of heavier iron isotopes into ferritin (which is removed from the body by regular
For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From apoptosis and shedding of epithelial cells into the lumen of the small intestine). In contrast to non-heme iron, it is unlikely that the iron isotope composition of heme-bound iron is affected during uptake by the intestinal epithelial cell. Relative mass differences of the heme isotopomers, which are taken up intact, are too small to cause a significant isotope effect during endocytosis. Subsequent release of iron from the heme molecule by heme-oxygenase is quantitative within epithelial cells and, therefore, cannot cause an isotope effect for reasons of mass balance. Besides isotope effects during absorption, the ratio between heme-bound iron and non-heme iron absorbed from the diet may influence the iron isotope signature of blood.
In an earlier survey, foods of animal origin were found to be more depleted in the heavier iron isotopes than plant foods. 19 However, results of more than 70 individuals (including unpublished data) do not indicate a significant difference in the iron isotopic composition of blood between vegetarians and omnivores.
Our recent findings support the hypothesis that the iron isotopic composition of blood is primarily determined by the efficiency at which iron is absorbed from the diet, i.e., an increased 56 Fe/ 54 Fe isotope ratio of blood reflects upregulated intestinal iron absorption:
(I) Iron homeostasis is maintained by the body by regulating intestinal iron absorption, however, control of intestinal absorption is ineffective in hereditary hemochromatosis.
Inappropriately enhanced intestinal absorption of iron, more accentuated for non-heme iron than heme-bound iron 25 , and inappropriately upregulated intestinal expression of DMT-1 26 have previously been reported in patients suffering from hereditary hemochromatosis. An increased 56 Fe/ 54 Fe isotope ratio of blood as observed in hemochromatosis patients is expected to be related with the underlying mechanism of the disorder.
(II) We found a higher 56 Fe/ 54 Fe isotope ratio in treated than in untreated hemochromatosis patients. According to our hypothesis, this finding would indicate that iron absorption is
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From upregulated more distinctly in hemochromatosis patients undergoing phlebotomy therapy than in untreated patients. Prior studies showed that intestinal expression of DMT-1 is increased in treated 26 but not in untreated 27 hemochromatosis patients. Other studies have shown that phlebotomy therapy per se causes a significant increase of intestinal iron absorption in hemochromatosis patients. 28, 29 (III) After initial iron depletion therapy, hemochromatosis patients reach a steady state of continuous intestinal iron (hyper)absorption which is balanced by iron depletion (phlebotomy) therapy in regular intervals. Phlebotomy requirements for maintaining steady state conditions are supposed to be higher in patients that absorb iron more efficiently. Hence, we would expect a more pronounced increase in the 56 Fe/ 54 Fe ratio of blood in patients phlebotomized more frequently. In the present study, we have found a significant correlation between the 56 Fe/ 54 Fe isotope ratio of blood and the annual amount of iron removed by phlebotomy to maintain body iron stores in steady state.
Blood of patients with hemochromatosis contains more of the heavier iron isotopes, i.e. is characterized by a higher 56 Fe/ 54 Fe isotope ratio, than blood of normal individuals because intestinal iron absorption is upregulated and, therefore, the isotope effect (i.e. preferential transfer of lighter isotopes) is less accentuated. However, processes related to inhomogenous distribution of iron isotopes between body compartments such as blood, liver and muscle may also contribute to our findings in hemochromatosis patients. Earlier investigations have shown that liver tissue is characterized by a higher 56 Fe/ 54 Fe isotope ratio than blood in humans. 19 If this is also the case in hemochromatosis patients, release of isotopically heavier liver iron during initial phlebotomy therapy and its subsequent utilization for erythropoiesis should result in an increase in the 56 Fe/ 54 Fe isotope ratio of blood until liver stores are emptied.
However, it appears that the iron isotopic signature of blood is not primarily determined by
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From the release of isotopically heavier liver iron since no correlation between the iron isotope composition of blood and total duration of phlebotomy therapy (continued up to 18 years) was observed. Once inappropriate iron stores of the liver are emptied, the iron isotope composition of blood should be determined mainly by continuously absorbed dietary iron which is presumed to reflect the efficiency at which iron is absorbed from the diet. In principle, hemoglobin concentration might be associated with the iron isotopic composition of blood, too, this however has not been systematically investigated in the present study.
Considering our recent results, it appears that we now have, basically, a method at our hands to determine the efficiency of intestinal (non-heme) iron absorption. The finding that the iron isotopic composition of blood is significantly associated with phenotypic expression of hereditary hemochromatosis can be considered as an early proof of concept. The method bears potential relevance as indicator for disorders affecting regulatory mechanisms of iron metabolism. [8] [9] [25] [26] [27] [28] Conventional tracer techniques are insensitive since intestinal iron absorption is subject to strong day-to-day variations. This is not the case for iron isotope effects in the blood which -if not perturbed -are stable during months or even years as recently shown. Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society
